Castration Sensitive Prostate Cancer
Oncology
10 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| docetaxel | PFIZER INC (PFE) |
Phase 3(3)
Unknown(5)
Phase 4(1)
| Drug | Company |
|---|---|
| abiraterone | PFIZER INC (PFE) |
Compare drugs
Frequently asked questions
How many drugs are in development for Castration Sensitive Prostate Cancer?
BioSniper tracks 10 drugs in development for Castration Sensitive Prostate Cancer across 2 companies.
How many clinical trials target Castration Sensitive Prostate Cancer?
There are 1 clinical trial targeting Castration Sensitive Prostate Cancer tracked by BioSniper.
Deep-dive into Castration Sensitive Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis